Sold as Diethylstilbestrol, Stilbestrol, Stilbetin. Every FDA application for this active ingredient: 4 branded and 6 generic.
As of Nov 15, 2026, FDA lists 10 applications for Diethylstilbestrol (sold as Diethylstilbestrol, Stilbestrol, Stilbetin), with 0 new uses approved and 0 published complete response letters.
| May 30, 1973 | StilbestrolANDA 83003 | Tablicaps | 0 | Discontinued |
| — | StilbestrolANDA 83002 | Tablicaps | 0 | Discontinued |
| — | StilbestrolANDA 83004 | Tablicaps | 0 | Discontinued |
| — | StilbestrolANDA 83005 | Tablicaps | 0 | Discontinued |
| — | StilbestrolANDA 83006 | Tablicaps | 0 | Discontinued |
| — | StilbestrolANDA 83007 | Tablicaps | 0 | Discontinued |
| — | DiethylstilbestrolNDA 4039 | Lilly | 0 | Discontinued |
| — | DiethylstilbestrolNDA 4040 | Lilly | 0 | Discontinued |
| — | DiethylstilbestrolNDA 4041 | Lilly | 0 | Discontinued |
| — | Stilbestrol, StilbetinNDA 4056 | Bristol Myers Squibb | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Lilly
Bristol Myers Squibb